Insider Transactions in Q2 2024 at Volitionrx LTD (VNRX)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 01
2024
|
Rodney Gerard Rootsaert Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
12,984
+10.53%
|
-
|
|
Jun 01
2024
|
Phillip Barnes |
BUY
Grant, award, or other acquisition
|
Direct |
8,011
+16.28%
|
-
|
|
Jun 01
2024
|
Nicholas Plummer GC, Volition Diagnostics |
BUY
Grant, award, or other acquisition
|
Direct |
10,249
+7.11%
|
-
|
|
Jun 01
2024
|
Salvatore Thomas Butera CEO, Volition Veterinary |
BUY
Grant, award, or other acquisition
|
Direct |
31,256
+11.93%
|
-
|
|
Jun 01
2024
|
Terig Hughes Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,686
+3.41%
|
-
|
|
Jun 01
2024
|
Kim Nguyen |
BUY
Grant, award, or other acquisition
|
Direct |
8,011
+12.98%
|
-
|
|
Jun 01
2024
|
Jasmine Kway CEO -Singapore Volition |
BUY
Grant, award, or other acquisition
|
Direct |
13,570
+10.28%
|
-
|
|
Jun 01
2024
|
Jacob Vincent Micallef Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,709
+11.98%
|
-
|
|
Jun 01
2024
|
Guy Archibald Innes |
BUY
Grant, award, or other acquisition
|
Direct |
16,022
+2.4%
|
-
|
|
Jun 01
2024
|
Michel Gaetan Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,689
+3.72%
|
-
|
|
Jun 01
2024
|
Gael Forterre Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,944
+6.12%
|
-
|
|
Jun 01
2024
|
Cameron John Reynolds President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
90,182
+4.66%
|
-
|
|
Jun 01
2024
|
Andrew Retter Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,326
+7.14%
|
-
|
|
Jun 01
2024
|
Alan Colman |
BUY
Grant, award, or other acquisition
|
Direct |
12,016
+5.7%
|
-
|
|
Jun 01
2024
|
Ann Louise Batchelor Group Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,685
+11.93%
|
-
|
|
May 23
2024
|
Andrew Retter Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+50.0%
|
-
|
|
May 01
2024
|
Salvatore Thomas Butera CEO, Volition Veterinary |
SELL
Payment of exercise price or tax liability
|
Direct |
15,504
-7.21%
|
$0
$0.87 P/Share
|